Skip to main content
      RT @synovialjoints: Add GPA to the list of causes of dacryoadenitis (inflammation of the lacrimal gland, main or access

      Dr. Antoni Chan synovialjoints

      3 years 10 months ago
      Add GPA to the list of causes of dacryoadenitis (inflammation of the lacrimal gland, main or accessory). Differential diagnoses of dacryoadenitis: ● Sjogren's ● Sarcoidosis ● IgG4 RD ● AL Amyloidosis ● GPA John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/dvXbkpfcAq
      RT @drdavidliew: After an incredible 2.5 years for the COVID-19 GRA @rheum_covid, @philipcrobinson addresses the celebra

      David Liew drdavidliew

      3 years 10 months ago
      After an incredible 2.5 years for the COVID-19 GRA @rheum_covid, @philipcrobinson addresses the celebration of all that’s been achieved at #ACR22 - followed by @JYazdanyMD @pedrommcmachado @rheum_cat and more Congratulations to all who have been involved! @RheumNow https://t.co/jO5c6yRI6F
      RT @synovialjoints: Learn the terms used by the ophthalmologists:

      ◦ KP
      ◦ PUK
      ◦ IOI
      ➢ PUK is a medical emergency

      Dr. Antoni Chan synovialjoints

      3 years 10 months ago
      Learn the terms used by the ophthalmologists: ◦ KP ◦ PUK ◦ IOI ➢ PUK is a medical emergency ➣ Think RA, AAV in PUK John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/yVGRpjrijN
      RT @RHEUMarampa: This quality improvement proj by Dr Gennaoui et al assessed MD compliance in HCQ eye screening 👇
      Aft

      sheila RHEUMarampa

      3 years 10 months ago
      This quality improvement proj by Dr Gennaoui et al assessed MD compliance in HCQ eye screening 👇 After an educ intervention, 👀 specialist documentation available ☑️significantly MD doc & uptodate screening also ⬆️not sig(p>0.05) Screen pts on HCQ. #ACR22 @RheumNow ABST#0346 https://t.co/IPAxXsp3Lu
      RT @synovialjoints: Doppelgängers are double walkers with similar features. GPA and IgG-RD are doppelgängers. 3 findin

      Dr. Antoni Chan synovialjoints

      3 years 10 months ago
      Doppelgängers are double walkers with similar features. GPA and IgG-RD are doppelgängers. 3 findings in GPA that are not found in IgG4-RD: ◦ Granulomatous inflammation ◦ Necrosis ◦ Neutrophilic infiltration John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/F67EhGBcS4
      Best of PsA on Day 1
      Hear what KOLs are saying about #ACR22. We are featuring Drs: Michele Petri, Peter Nash, Artie Kavanaugh, Jack Cush. Fo

      Dr. John Cush RheumNow

      3 years 10 months ago
      Hear what KOLs are saying about #ACR22. We are featuring Drs: Michele Petri, Peter Nash, Artie Kavanaugh, Jack Cush. Follow us on Twitter and head to https://t.co/V10S4oVFsv! https://t.co/uRZLffesrq
      RT @DrTrishHarkins: Delighted to have caught up with ⁦@SattuiSEMD⁩ to discuss his Abst #0444- Frailty and it’s ass

      Patricia Harkins DrTrishHarkins

      3 years 10 months ago
      Delighted to have caught up with ⁦@SattuiSEMD⁩ to discuss his Abst #0444- Frailty and it’s associated factors in vasculitis #ACR22 ⁦@RheumNow⁩ https://t.co/r2740kuQET
      RT @synovialjoints: Treating the underlying CTD is key to managing ILD in combination with anti-fibrotic. In the SENCIS

      Dr. Antoni Chan synovialjoints

      3 years 10 months ago
      Treating the underlying CTD is key to managing ILD in combination with anti-fibrotic. In the SENCIS study, patients on combination of MMF at baseline +Nintedanib had reduced decline in FVC compared to Nintedanib alone https://t.co/NmVRZ44JGE Paul Noble #ACR22 @RheumNow https://t.co/mulaBK61ga
      PsA Cycling or Switching MOAs
      The RheumNow faculty reporters have been scouring the meeting and online presentations to find the best abstracts from ACR22. Here are some of their choice abstracts reported today on day 1 of ACR 2022 (#ACRbest).  
      Join us for our daily topic panels--we'll be live on Twitter, LinkedIn, FB and YouTube OR sign up directly below.

      https

      Dr. John Cush RheumNow

      3 years 10 months ago
      Join us for our daily topic panels--we'll be live on Twitter, LinkedIn, FB and YouTube OR sign up directly below. https://t.co/lZK8vsySiD https://t.co/smUveqf3C6
      ×